Penn Medicine: University of Pennsylvania Health System-Heme/Onc ( Site 0127) is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Penn Medicine: University of Pennsylvania Health System-Heme/Onc ( Site 0127) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Penn Medicine: University of Pennsylvania Health System-Heme/Onc ( Site 0127) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Penn Medicine: University of Pennsylvania Health System-Heme/Onc ( Site 0127) has 1 clinical trials on record, with 1 currently active. Their work covers Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease.
Penn Medicine: University of Pennsylvania Health System-Heme/Onc ( Site 0127) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.